Renalytix AI
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a… Read more
Market Cap & Net Worth: Renalytix AI (RNLX)
Renalytix AI (NASDAQ:RNLX) has a market capitalization of $11.67 Million ($11.67 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26462 globally and #8952 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Renalytix AI's stock price $0.14 by its total outstanding shares 82962800 (82.96 Million).
Renalytix AI Market Cap History: 2020 to 2024
Renalytix AI's market capitalization history from 2020 to 2024. Data shows change from $1.33 Billion to $11.67 Million (-64.63% CAGR).
Renalytix AI Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Renalytix AI's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.10x
Renalytix AI's market cap is 5.10 times its annual revenue
1.54x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.32 Billion | $1.49 Million | -$34.73 Million | 884.71x | N/A |
| 2022 | $155.14 Million | $2.97 Million | -$45.28 Million | 52.24x | N/A |
| 2023 | $32.36 Million | $3.40 Million | -$45.61 Million | 9.51x | N/A |
| 2024 | $11.67 Million | $2.29 Million | -$33.46 Million | 5.10x | N/A |
Competitor Companies of RNLX by Market Capitalization
Companies near Renalytix AI in the global market cap rankings as of March 18, 2026.
Key companies related to Renalytix AI by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Renalytix AI Historical Marketcap From 2020 to 2024
Between 2020 and today, Renalytix AI's market cap moved from $1.33 Billion to $ 11.67 Million, with a yearly change of -64.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $11.67 Million | -63.92% |
| 2023 | $32.36 Million | -79.14% |
| 2022 | $155.14 Million | -88.24% |
| 2021 | $1.32 Billion | -0.62% |
| 2020 | $1.33 Billion | -- |
End of Day Market Cap According to Different Sources
On Dec 5th, 2025 the market cap of Renalytix AI was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.67 Million USD |
| MoneyControl | $11.67 Million USD |
| MarketWatch | $11.67 Million USD |
| marketcap.company | $11.67 Million USD |
| Reuters | $11.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.